Uzbekistan and Tajikistan will receive vaccines against coronavirus as part of Germany's promised supplies to developing countries, announced on August 9 in Berlin the deputy official representative of the Federal government Ulrike Demmer, Deutsche Welle said.
According to her, 355.2 thousand doses will be provided to Tashkent, and 100.8 thousand doses to Dushanbe. Other recipient countries will be Sudan (357.6 thousand), Ethiopia (271.2 thousand) and Afghanistan (213.6 thousand).
The decision that Germany will provide 30 million doses by the end of the year, primarily to developing countries was made at the Global Health Summit on May 21 in Rome.
The vaccines will be supplied primarily through the global COVAX facility, which aims to provide countries around the world with equitable access to safe and effective vaccines once licensed and registered. This initiative is jointly coordinated by the Coalition for Epidemic Preparedness Innovation (CEPI), the Global Alliance for Vaccines and Immunization (GAVI) and the World Health Organization (WHO).
The vaccines to be supplied will be the Swedish-manufactured AstraZeneca, obtained by Berlin under contracts with London, DW added.
According to Ulrike Demmer, the beneficiaries will be countries where, according to WHO and GAVI estimates, the need for vaccination is especially high and where the jabs can immediately be used as part of the vaccination campaign.
As of August 8, more than 10 million doses of vaccines have been used in Uzbekistan. The first dose was received by 6.8 million people, the second - 2.3 million, the third - 887.9 thousand. Over 1.3 million people have received the full course of vaccinations.
As of August 6, the total vaccine reserve in Uzbekistan reached 14.58 million doses. In total, the country has received 10.5 million doses of ZF-UZ-VAC2001 so far. In addition, 3 million doses of Moderna, 710 thousand doses of AstraZeneca and 370 thousand doses of Sputnik V were delivered.
